---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-23-000074"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T04:53:25.233453+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics updates corporate presentation for investor meetings

## Summary
- On August 7, 2023, Context Therapeutics updated its corporate presentation for use in investor meetings.
- The presentation was filed as Exhibit 99.1 to Form 8-K.
- The company's CEO Martin A. Lehr signed the filing.
- The presentation includes information about advancing medicines for solid tumors.

## SEC filing metadata
- accession: 0001842952-23-000074
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295223000074/0001842952-23-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295223000074/cntx-20230807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-23-000074
- JSON: https://secwatch.observer/filing/0001842952-23-000074.json
- Plain text: https://secwatch.observer/filing/0001842952-23-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.